2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors
申请人:Merck Sharp & Dohme Corp.
公开号:US11377438B2
公开(公告)日:2022-07-05
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Nav1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Nav1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.